Making Liver Transplantation Affordable

Published on May 15, 2019 by Lam S in In the News

Aster clinical transplant nursing program

Published on Sep 11, 2017 by Nii in In the News

The three month certificate course(9 June 2017 to 9 sept 2017)in transplantation nursing concluded today. 30 nurses from four hospitals in three states attended. There was a two month online didactic program with live lectures from within India and abroad followed by a one month competency and skills assessment, as well as peer initiated teaching and shadowing senior nurses in icu. Lalita and Sumana from Mohan foundation conducted the soft skills and communication course.Mohan foundation conducted the grief counseling and communications skills course.

This is the first course of its kind in India it combines a unique hybrid format of online + immersion for short periods of intense training. Training was imparted by doctors and nursing tutors. Soft skills communication and grief counseling are integral skills to medicine today’s, and were part of the curriculum

Addressing the group Dr Nitish Shetty, CEO said that it is increasingly recognized that nurses also need subspecialty skills and training to meet the demands of quarter nary specialties such as transplant.

A fatty liver leads to a broken heart?

Published on Jun 15, 2016 by Nii in In the News

Strict Monitoring of Cardiovascular Disease Recommended When Managing Nonalcoholic Fatty Liver Disease

Cardiovascular disease (CVD) is primarily the cause of death of patients with nonalcoholic fatty liver disease (NAFLD). The extent to which NAFLD itself, rather than associated conditions such as diabetes, obesity, or dyslipidemia, is responsible for increased cardiovascular death has been a matter of debate. In a new study, investigators from the Pitié-Salpêtrière Hospital, Pierre and Marie Curie University conclude that NAFLD is an independent risk factor for atherosclerosis and therefore CVD. Their findings, published in the Journal of Hepatology, recommend strict monitoring of cardiovascular health and metabolic complications in patients with NAFLD.

Fatty liver is an increasingly common condition in patients with obesity, type 2 diabetes, dyslipidemia and hypertension. Evidence indicates that the fatty and inflamed liver expresses several pro-inflammatory and procoagulant factors, as well as genes involved in accelerated atherogenesis. This raises the possibility that the link between NAFLD and cardiovascular mortality might not simply be mediated by shared, underlying, common risk factors, but rather that fatty liver independently contributes to increasing this risk.

Close to 6000 patients were examined using carotid ultrasound with measurement of carotid intima-media thickness and carotid plaques. Using the Fatty Liver Index (FLI) a well-validated biomarker panel, researchers observed that steatosis (fatty liver) is associated with carotid intima-media thickness (C-IMT), a pre-atherosclerotic lesion that predicts cardiovascular events. C-IMT increased proportionally with FLI, and this association was independent of traditional cardio-metabolic risk factors.

The team concluded that in patients with metabolic syndrome at risk for cardiovascular events, NAFLD contributes to early atherosclerosis and its progression, independent of traditional cardiovascular risk factors.

“Regardless of the mechanisms involved, the clinical implications are of critical importance since patients at cardiovascular risk presenting with one or more metabolic syndrome characteristics are at even greater risk if they have steatosis. It was also found that patients with steatosis, but not overweight, not type 2 diabetic, or without arterial hypertension are at higher risk of developing these complications than individuals without steatosis. This indicates that NAFLD is a precursor of metabolic syndrome. It follows that the diagnosis of steatosis is extremely important and therefore a thorough cardiovascular and metabolic work-up and strict monitoring of CVD or metabolic complications are needed in the clinical management of NAFLD.